Što znači "Očistiti"?
Životinja ne nosi mutaciju. Neće razviti bolest i neće ga prenijeti.
Discover the benefits of a DNA test for Intestinal Lipid Malabsorption (ILM) in dogs. This genetic screening helps identify predispositions to ILM, a condition that affects nutrient absorption and can lead to serious health issues. Early detection through DNA testing allows pet owners to implement dietary changes and management strategies tailored to their dog's needs. By understanding your dog's genetic makeup, you can ensure a healthier, happier life. Invest in a DNA test today to safeguard your furry friend's well-being and enhance their quality of life. Don't wait—take proactive steps towards your dog's health with an ILM DNA test!
Intestinal Lipid Malabsorption (ILM) is a condition in dogs that affects their ability to properly absorb fats from food. This can lead to symptoms such as weight loss, diarrhea, and poor coat condition. A DNA test for ILM can help identify genetic predispositions, allowing for early intervention and management. Understanding a dog's genetic makeup can guide dietary adjustments and treatment plans. Early detection through testing is crucial for improving the quality of life in affected dogs.
Ovaj DNK test je uključen počevši od našeg paketa Basic — i također je dio paketa Basic, Standard, Advanced, Complete.
Pogledajte pakete DNK testova →Intestinal Lipid Malabsorption (ILM) is a condition in dogs characterized by the inability to properly absorb fats and lipids from the diet. This malabsorption can lead to a variety of health issues, including nutritional deficiencies, weight loss, and gastrointestinal upset. Understanding ILM is crucial for pet owners and veterinarians alike, as it can significantly impact a dog's quality of life.
ILM can arise from several underlying causes, including genetic predispositions, infections, inflammatory diseases, and anatomical abnormalities of the gastrointestinal tract. Genetic factors play a significant role in some cases, where specific mutations can disrupt the normal functioning of intestinal cells responsible for fat absorption. Additionally, conditions like exocrine pancreatic insufficiency or intestinal inflammation can further complicate the absorption process.
Dogs suffering from ILM may exhibit a range of symptoms that can vary in severity. Common signs include chronic diarrhea, weight loss despite a normal or increased appetite, and the presence of fatty stools (steatorrhea) that may appear oily or foul-smelling. Other symptoms can include lethargy, dehydration, and overall poor condition. Recognizing these symptoms early is essential for prompt diagnosis and treatment.
Diagnosing ILM typically involves a combination of clinical evaluations, dietary assessments, and specific diagnostic tests. Veterinarians may recommend blood tests to check for nutritional deficiencies and conduct fecal examinations to identify the presence of undigested fats. Advanced imaging techniques, such as ultrasound or endoscopy, may also be employed to assess the structure and function of the gastrointestinal tract.
Managing ILM often requires a multifaceted approach. Dietary modifications are crucial, with a focus on providing easily digestible, low-fat diets that minimize the burden on the digestive system. In some cases, supplementation with digestive enzymes or probiotics may be beneficial to enhance nutrient absorption. Treating any underlying conditions, such as infections or inflammation, is also a vital part of the therapeutic strategy.
The prognosis for dogs with ILM varies depending on the underlying cause and the effectiveness of the treatment plan. Some dogs may respond well to dietary changes and supportive care, while others may require long-term management strategies to maintain their health. Regular veterinary check-ups and monitoring are essential to ensure that the dog remains stable and to adjust treatment as necessary.
Intestinal Lipid Malabsorption is a significant health concern for dogs that can lead to serious nutritional deficits and overall poor health. Early recognition of symptoms and prompt intervention are critical for improving outcomes. With appropriate dietary management and veterinary care, many dogs with ILM can lead healthy, fulfilling lives.
Životinja ne nosi mutaciju. Neće razviti bolest i neće ga prenijeti.
Ne. Životinja je općenito zdrava, ali može prenijeti mutaciju na svoju potomstvo.
Nosi dvije mutirane kopije. Klinički znakovi se očekuju ovisno o bolest. Ne treba ga uzgajati.
Neke bolesti su spolno povezane, pa njihov izraz varira ovisno o spol životinje.
This DNA test detects the mutation associated with Intestinal Lipid Malabsorption (ILM) in order to identify clear, carrier, or at-risk animals.
DNK testiranje pomaže uzgajivačima u planiranju sigurnijih parenja i smanjenju rizika od prijenosa mutacije na potomstvo.
Način nasljeđivanja prijavljen za ovaj test je autosomno recesivan.
This test analyses the mutation ACSL5 g.23380074_23483377del.
Nije nužno. Tumačenje ovisi o obrascu nasljeđivanja i rezultirajućem genotipu.
O'Brien Mitchell J, Beijerink Niek J, Sansom Mandy, Thornton Sarah W, Chew Tracy, Wade Claire M. A large deletion on CFA28 omitting ACSL5 gene is associated with intestinal lipid malabsorption in the Australian Kelpie dog breed. Sci Rep. 2020 Oct 26;10(1):18223. doi: 10.1038/s41598-020-75243-x.
Vaša privatnost, vaš izbor
Koristimo bitne kolačiće za rad web stranice. Neobavezni kolačići (kao što su ugrađeni davatelji sadržaja) onemogućeni su prema zadanim postavkama i omogućeni su samo ako se slažete. Svoj odabir možete promijeniti bilo kada pomoću gumba "Kolačići".
Potrebno za osnovne značajke i sigurnost. Uvijek omogućeno.
Poboljšava značajke poput spremanja postavki ili ugrađivanja bez oglašavanja.
Pomaže nam razumjeti korištenje stranice. Onemogućeno prema zadanim postavkama.
Oglašavanje/praćenje na web-lokacijama (ugrađeni neki videozapisi/karte). Onemogućeno prema zadanim postavkama.